Core Laboratories (CLB) Projected to Post Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) will likely be releasing its Q1 2025 earnings data after the market closes on Wednesday, April 23rd. Analysts expect Core Laboratories to post earnings of $0.15 per share and revenue of $125.09 million for the quarter. Core Laboratories has set its Q1 2025 guidance at 0.120-0.160 EPS.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Price Performance

CLB opened at $12.23 on Tuesday. Core Laboratories has a fifty-two week low of $10.14 and a fifty-two week high of $25.13. The firm has a 50-day moving average of $14.44 and a 200 day moving average of $17.37. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. The firm has a market cap of $571.17 million, a P/E ratio of 18.53, a PEG ratio of 0.99 and a beta of 1.99.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Monday, February 10th. Core Laboratories’s dividend payout ratio is currently 6.06%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Citigroup upgraded Core Laboratories from a “sell” rating to a “neutral” rating and boosted their target price for the company from $15.00 to $16.00 in a research note on Wednesday, March 12th. Stifel Nicolaus dropped their price objective on shares of Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a report on Tuesday, April 15th. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $15.75.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.